Decay-accelerating factor regulates T-cell immunity in the context of inflammation by influencing costimulatory molecule expression on antigen-presenting cellsCHONGYUN FANG; MIWA, Takashi; SONG, Wen-Chao et al.Blood. 2011, Vol 118, Num 4, pp 1008-1014, issn 0006-4971, 7 p.Article

Decay-Accelerating Factor Binding Determines the Entry Route of Echovirus 11 in Polarized Epithelial CellsSOBO, Komla; RUBBIA-BRANDT, Laura; BROWN, T. David K et al.Journal of virology. 2011, Vol 85, Num 23, pp 12376-12386, issn 0022-538X, 11 p.Article

Acquisition of Complement Resistance through Incorporation of CD55/Decay-Accelerating Factor into Viral Particles Bearing Baculovirus GP64KANAME, Yuuki; TANI, Hideki; KATAOKA, Chikako et al.Journal of virology. 2010, Vol 84, Num 7, pp 3210-3219, issn 0022-538X, 10 p.Article

Interaction of Decay-Accelerating Factor with Echovirus 7PLEVKA, Pavel; HAFENSTEIN, Susan; ROSSMANN, Michael G et al.Journal of virology. 2010, Vol 84, Num 24, pp 12665-12674, issn 0022-538X, 10 p.Article

Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infectionNEWCOMBE, Nicole G; JOHANSSON, E. Susanne; AU, Gough et al.Journal of virology. 2004, Vol 78, Num 3, pp 1431-1439, issn 0022-538X, 9 p.Article

Unique expression of HRF20 (CD59) in human nervous tissueAKATSU, H; YAMADA, T; OKADA, N et al.Microbiology and immunology. 1997, Vol 41, Num 4, pp 321-329, issn 0385-5600Article

Single Amino Acid Changes in the Virus Capsid Permit Coxsackievirus B3 To Bind Decay-Accelerating FactorJIEYAN PAN; NARAYANAN, Bhargavi; SHAH, Shardule et al.Journal of virology. 2011, Vol 85, Num 14, pp 7436-7443, issn 0022-538X, 8 p.Article

Dynamin- and Lipid Raft-Dependent Entry of Decay-Accelerating Factor (DAF)-Binding and Non-DAF-Binding Coxsackieviruses into Nonpolarized CellsPATEL, Kunal P; COYNE, Carolyn B; BERGELSON, Jeffrey M et al.Journal of virology. 2009, Vol 83, Num 21, pp 11064-11077, issn 0022-538X, 14 p.Article

Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1NICKELLS, M. W; ALVAREZ, J. I; LUBLIN, D. M et al.The Journal of immunology (1950). 1994, Vol 152, Num 2, pp 676-685, issn 0022-1767Article

Expression of decay-accelerating factor (CD55) of the complement system on human spermatozoaCERVONI, F; OGLESBY, T. J; FENICHEL, P et al.The Journal of immunology (1950). 1993, Vol 151, Num 2, pp 939-948, issn 0022-1767Article

Decay-accelerating factor prevents acute humoral rejection induced by low levels of anti-αGal natural antibodiesSHIMIZU, Ichiro; SMITH, Neal R; GUILING ZHAO et al.Transplantation. 2006, Vol 81, Num 1, pp 95-100, issn 0041-1337, 6 p.Article

The influence of baseline expression of human decay accelerating factor transgene on graft survival and acute humoral xenograft rejectionHONGTAO SUN; GANG CHEN; WEIHUA LIU et al.Transplantation. 2005, Vol 80, Num 9, pp 1331-1339, issn 0041-1337, 9 p.Article

Novel role for decay-accelerating factor in coxsackievirus A21-mediated cell infectivityNEWCOMBE, Nicole G; BEAGLEY, Leone G; CHRISTIANSEN, Dale et al.Journal of virology. 2004, Vol 78, Num 22, pp 12677-12682, issn 0022-538X, 6 p.Article

Suppressed complement activation in human decay accelerating factor transgenic porcine liver cross-circulated with nonhuman primatesMATSUSHITA, Takakazu; IKAI, Iwao; YAMAOKA, Yoshio et al.Transplantation. 2003, Vol 75, Num 11, pp 1807-1812, issn 0041-1337, 6 p.Article

Identification of the 80-kDa LPS-binding protein (LMP80) as decay-accelerating factor (DAF, CD55)EL-SAMALOUTI, V. T; SCHLETTER, J; CHYLA, I et al.FEMS immunology and medical microbiology. 1999, Vol 23, Num 3, pp 259-269, issn 0928-8244Article

Decay-accelerating factor and cytoskeleton redistribution pattern in HeLa cells infected with recombinant Escherichia coli strains expressing Dr family of adhesinsGOLUSZKO, P; SELVARANGAN, R; POPOV, V et al.Infection and immunity. 1999, Vol 67, Num 8, pp 3989-3997, issn 0019-9567Article

Rapid cyclic changes in density and accessibility of endometrial ligands for Escherichia coli Dr fimbriaeKAUL, A. K; DHRUV KUMAR; NAGAMANI, M et al.Infection and immunity. 1996, Vol 64, Num 2, pp 611-615, issn 0019-9567Article

Presence of dysfunction form of CD59 on a CD59⁺ subclone of the U937 cell lineVAN DEN BERG, C. W; WILLIAMS, O. M; MORGAN, B. P et al.Immunology (Oxford). 1994, Vol 81, Num 4, pp 637-642, issn 0019-2805Article

Release of vesicles enriched in complement receptor 1 from human erythrocytesPASCUAL, M; LUTZ, H. U; STEIGER, G et al.The Journal of immunology (1950). 1993, Vol 151, Num 1, pp 397-404, issn 0022-1767Article

Complement regulatory proteins in early human fetal life : CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liverSIMPSON, K. L; HOULIHAN, J. M; HOLMES, C. H et al.Immunology (Oxford). 1993, Vol 80, Num 2, pp 183-190, issn 0019-2805Article

Expression of decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 in the human astroglioma cell line, D54-MG, and primary rat astrocytesCHENYIN YANG; JONES, J. L; BARNUM, S. R et al.Journal of neuroimmunology. 1993, Vol 47, Num 2, pp 123-132, issn 0165-5728Article

Human Decay-Accelerating Factor and CEACAM Receptor-Mediated Internalization and Intracellular Lifestyle of Afa/Dr Diffusely Adhering Escherichia coli in Epithelial CellsGUIGNOT, Julie; HUDAULT, Sylvie; KANSAU, Imad et al.Infection and immunity. 2009, Vol 77, Num 1, pp 517-531, issn 0019-9567, 15 p.Article

Decay-accelerating Factor Expression May Provide Immunoprotection Against Antibody-mediated Cardiac Allograft RejectionGONZALEZ-STAWINSKI, Gonzalo V; TAN, Carmela D; SMEDIRA, Nicholas G et al.The Journal of heart and lung transplantation. 2008, Vol 27, Num 4, pp 357-361, issn 1053-2498, 5 p.Article

Hantavirus Causing Hemorrhagic Fever with Renal Syndrome Enters from the Apical Surface and Requires Decay-Accelerating Factor (DAF/CD55)KRAUTKRÄMER, Ellen; ZEIER, Martin.Journal of virology. 2008, Vol 82, Num 9, pp 4257-4264, issn 0022-538X, 8 p.Article

Combined yeast 3-glucan and antitumor monoclonal antibody therapy requires c5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55BING LI; ALLENDORF, Daniel J; HANSEN, Richard et al.Cancer research (Baltimore). 2007, Vol 67, Num 15, pp 7421-7430, issn 0008-5472, 10 p.Article